Phase I: Validating self-collection kit by comparing their results with clinical Pap smear results in a cohort of 20 patients.

Phase II: Evaluate the feasibility and acceptability of the CHW4CervicalHealth: Use of a self-collection kit to improve cervical health screening intervention aimed to promote HPV self-collection uptake among screening-eligible and under-screened ethnic minority women in the community.

The self-collection kits will be collected at the clinic (Phase I) or at the end of the workshop (Phase II). A chain-of-custody form for each kit will be associated with the specimen and the clinic nurse will label and prepare to transport them via courier to the Jefferson NJ Molecular Virology lab, Cherry Hill, NJ; Richard Sunday, Lab Supervisor, will process according to Roche, the self-collected vaginal specimens suspended in PreservCyt® may be stored at 2-30°C (35.6- 86°F) for up to 1 month after the date of collection.

Phase I: In person accrual, enrollment and study implementation will take 15-30 minutes.

-Clinic staff will collect self-collection kit at appointment.

Phase II: Workshops will take about 30 minutes to complete and another 30 minutes to complete survey and self-collection kit use.

• Conduct educational workshops in participants primary language
• For those choosing to use the self-sample kit, obtain and document e-consent or paper consent from potential participants in their primary language.
• Provide participants with self-collection testing kits during workshop along with instructions
• Collect self-collection kit samples from participants and place in pre-made sample bags with appropriate label. CHW will take custody and coordinate with OBGYN clinic staff to drop off self-collected samples
• Collect post workshop survey and conduct post workshop interviews or focus group
• OBGYN staff set-up courier to send samples to NJ lab

Inclusion Criteria:

Phase I:

• Women aged 25-65 years
• Scheduled for a Pap smear test appointment at Jefferson OBGYN Center City location
• Willing and able to provide informed consent for participation in the study
• Agree to perform an HPV self-collection collection procedure during the same visit
• Have not undergone a hysterectomy (intact cervix required)

Phase II:

This intervention targets under-screened minority individuals who must meet all the following inclusion criteria to be eligible to participate in the study:

• Women aged 25-65 years
• Who has not had a Pap smear in the past three to five years based on age of prior screening and type of screening. If under the age of 30, in the past 3 years and if over the age of 30, in the past 5 years. Participant will self-report normal pap smear and date.
• Self-identify as Hispanic, Black/African or Black Caribbean, Chinese, Korean, or Vietnamese
• Competent to give consent and provide signed and dated informed consent form in their preferred language.

Exclusion Criteria:

Phase I:

• Current pregnancy (self-reported or confirmed)
• Previous participation in an HPV self-collection study within the past 12 months
• Presence of visible vaginal or cervical infection or symptoms suggestive of a current genital tract infection
• Inability to comply with study procedures or follow instructions (e.g., due to language barriers or cognitive impairments)

Phase II:

An individual who meets any of the following criteria will be excluded from participation in this study:

• Have a history of hysterectomy, cervical cancer
• Self-report participation in a cervical cancer screening or other prevention study
• Pregnant (self-reported)
• Inability to provide informed consent